Laura Esteban-Burgos

Laura Esteban-Burgos

Auto-generated profile, based on publicly available information

Laura Esteban-Burgos

Eli Lilly and Company, Indianapolis, IN 46285, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Cancer Cell
Verified
Journal Article
Closed access
MSManuel Sanclemente
Manuel Sanclemente
SFSarah Francoz
Sarah Francoz
LELaura Esteban-Burgos
Laura Esteban-Burgos
EBEmilie Bousquet-Mur
Emilie Bousquet-Mur
MDMagdolna Djurec
Magdolna Djurec
MBMariano Barbacid
Mariano Barbacid

1 April 2019 in Cancer Cell
Verified
Journal Article
Closed access
MBMaría Teresa Blasco
María Teresa Blasco
CNCarolina Navas
Carolina Navas
GMGuillermo Martín-Serrano
Guillermo Martín-Serrano
OGOsvaldo Graña-Castro
Osvaldo Graña-Castro
CLCarmen G. Lechuga
Carmen G. Lechuga
MBMariano Barbacid
Mariano Barbacid

2 August 2017 in Nature
Verified
Journal Article
Closed access
PDF file
PNPatricia Nieto
Patricia Nieto
CAChiara Ambrogio
Chiara Ambrogio
LELaura Esteban-Burgos
Laura Esteban-Burgos
Gonzalo Gomez-LopezGonzalo Gomez-Lopez
Gonzalo Gomez-Lopez
MBMaría Teresa Blasco
María Teresa Blasco
David SantamariaDavid Santamaria
David Santamaria

5 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IFIrene Fernández-Ruiz
Irene Fernández-Ruiz
FAFrancisco Arnalich
Francisco Arnalich
CCCarolina Cubillos-Zapata
Carolina Cubillos-Zapata
Enrique Hernandez JimenezEnrique Hernandez Jimenez
Enrique Hernandez Jimenez
RMRaúl Moreno-González
Raúl Moreno-González
ELEduardo Lopez-Collazo
Eduardo Lopez-Collazo
Monocyte exposure to mitochondrial Danger Associated Molecular Patterns (DAMPs), including mitochondrial DNA (mtDNA), induces a transient state in which these cells are refractory to further endotoxin stimulation. In this context, IRAK-M up-regulation and impaired p65 activity were observed. This phenomenon, termed endotoxin tolerance (ET), is characterized by decreased production of cytokines in response to the pro-inflammatory stimulus. We also show that monocytes isolated from patients with myocardial infarction (MI) exhibited high levels of circulating mtDNA, which correlated with ET status. Moreover, a significant incidence of infection was observed in those patients with a strong tolerant phenotype. The present data extend our current understanding of the implications of endotoxin tolerance. Furthermore, our data suggest that the levels of mitochondrial antigens in plasma, such as plasma mtDNA, should be useful as a marker of increased risk of susceptibility to nosocomial infections in MI and in other pathologies involving tissue damage.

15 January 2015 in The Journal of Immunology
Verified
Journal Article
Closed access
TJTeresa Jurado-Camino
Teresa Jurado-Camino
RCRaúl Córdoba
Raúl Córdoba
LELaura Esteban-Burgos
Laura Esteban-Burgos
Enrique Hernandez JimenezEnrique Hernandez Jimenez
Enrique Hernandez Jimenez
VTVictor Toledano
Victor Toledano
ELEduardo Lopez-Collazo
Eduardo Lopez-Collazo
Infections are a significant cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). The pathogenesis of infections is multifactorial and includes hypogammaglobulinemia, conventional therapy with alkylating drugs, and recently, purine analogs and mAb-associated T cells. Patients without these risk factors also suffer from infections, although the mechanism remains unknown. In a cohort of 70 patients with CLL, we demonstrated that their monocytes were locked into a refractory state and were unable to mount a classic inflammatory response to pathogens. In addition, they exhibited the primary features of endotoxin tolerance, including low cytokine production, high phagocytic activity, and impaired Ag presentation. The involvement of miR-146a in this phenomenon was suspected. We found miR-146a target genes, such as IRAK1 and TRAF6, were manifestly downregulated. Our study provides a new explanation for infections in patients with CLL and describes a cross-tolerance between endotoxins and tumors.

15 October 2014 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CCCarolina Cubillos-Zapata
Carolina Cubillos-Zapata
Enrique Hernandez JimenezEnrique Hernandez Jimenez
Enrique Hernandez Jimenez
VTVíctor Toledano
Víctor Toledano
LELaura Esteban-Burgos
Laura Esteban-Burgos
IFIrene Fernández-Ruíz
Irene Fernández-Ruíz
ELEduardo Lopez-Collazo
Eduardo Lopez-Collazo
Endotoxin tolerance (ET) is a state of reduced responsiveness to endotoxin stimulation after a primary bacterial insult. This phenomenon has been described in several pathologies, including sepsis, in which an endotoxin challenge results in reduced cytokine production. In this study, we show that the NFκ L chain enhancer of activated B cells 2 (NFκB2)/p100 was overexpressed and accumulated in a well-established in vitro human monocyte model of ET. The p100 accumulation in these cells inversely correlated with the inflammatory response after LPS stimulation. Knocking down NFκB2/p100 using small interfering RNA in human monocytes further indicated that p100 expression is a crucial factor in the progression of ET. The monocytes derived from patients with sepsis had high levels of p100, and a downregulation of NFκB2/p100 in these septic monocytes reversed their ET status.